ESTABLISHING CHIRONOMUS LARVAE AS AN ETHICALLY SOUND AND EFFICIENT SYSTEM FOR EARLY-STAGE ANTHELMINTIC SCREENING

The escalating global challenge of helminthic infections, compounded by widespread anthelmintic drug resistance and the inherent limitations of traditional in vivo screening models (e.g., high cost, ethical concerns, low throughput), necessitates the urgent development of novel, efficient, and ethically sound drug discovery platforms. This paper proposes and elaborates on the strategic imperative for establishing Chironomus larvae (commonly known as bloodworms) as a robust in vitro model for early-stage anthelmintic efficacy screening. Chironomus species offer a unique confluence of biological and practical advantages.Their rapid life cycle, ease of laboratory cultivation,and remarkable robustness enable high-throughput screening, significantly reducing economic and logistical burdens. Crucially, their comparative physiological and anatomical commonalities with helminths, particularly concerning the chitinous cuticle, complete digestive system,complex nervous system, and conserved detoxification pathways, establish strong biological relevance, enhancing predictive value for identifying compounds active against parasitic worms. As invertebrates, their use aligns perfectly with the 3Rs (Replacement, Reduction, Refinement) ethical framework. Leveraging the established precedent of Chironomus larvaein ecotoxicology and its amenability to advanced phenotypic profiling techniques, including high-content imaging and behavioral analysis, allows for detection of both overt and subtle cryptic anthelmintic effects. This multi parametric approach provides comprehensive understanding of bioactivity. By embracing Chironomus larvae, this strategic shift in anthelmintic drug discovery not only addresses critical ethical concerns but also optimizes resource allocation, accelerating the identification of promising natural product candidates, such as those from potent traditionally reported plants that are known to be used for their anthelminthic properties, and contributing to the urgent global need for novel and effective treatments against parasitic helminths.

Authors

Publication Details

Journal
International Journal of Advanced Research
Published
2025-07-24
DOI
https://doi.org/10.21474/ijar01/21265
Primary Topic
Insects and Parasite Interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ESTABLISHING CHIRONOMUS LARVAE AS AN ETHICALLY SOUND AND EFFICIENT SYSTEM FOR EARLY-STAGE ANTHELMINTIC SCREENING

Manish Joshi
International Journal of Advanced Research
Insects and Parasite Interactions
article

ESTABLISHING CHIRONOMUS LARVAE AS AN ETHICALLY SOUND AND EFFICIENT SYSTEM FOR EARLY-STAGE ANTHELMINTIC SCREENING

Manish Joshi
article en

Abstract

The escalating global challenge of helminthic infections, compounded by widespread anthelmintic drug resistance and the inherent limitations of traditional in vivo screening models (e.g., high cost, ethical concerns, low throughput), necessitates the urgent development of novel, efficient, and ethically sound drug discovery platforms. This paper proposes and elaborates on the strategic imperative for establishing Chironomus larvae (commonly known as bloodworms) as a robust in vitro model for early-stage anthelmintic efficacy screening. Chironomus species offer a unique confluence of biological and practical advantages.Their rapid life cycle, ease of laboratory cultivation,and remarkable robustness enable high-throughput screening, significantly reducing economic and logistical burdens. Crucially, their comparative physiological and anatomical commonalities with helminths, particularly concerning the chitinous cuticle, complete digestive system,complex nervous system, and conserved detoxification pathways, establish strong biological relevance, enhancing predictive value for identifying compounds active against parasitic worms. As invertebrates, their use aligns perfectly with the 3Rs (Replacement, Reduction, Refinement) ethical framework. Leveraging the established precedent of Chironomus larvaein ecotoxicology and its amenability to advanced phenotypic profiling techniques, including high-content imaging and behavioral analysis, allows for detection of both overt and subtle cryptic anthelmintic effects. This multi parametric approach provides comprehensive understanding of bioactivity. By embracing Chironomus larvae, this strategic shift in anthelmintic drug discovery not only addresses critical ethical concerns but also optimizes resource allocation, accelerating the identification of promising natural product candidates, such as those from potent traditionally reported plants that are known to be used for their anthelminthic properties, and contributing to the urgent global need for novel and effective treatments against parasitic helminths.

International Journal of Advanced ResearchVol. 13(07)
Openalex Percentile: Top 77%
Insects and Parasite Interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.